Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

Sep 6, 2018

30786_dirs_2018-09-06_f56467f5-291f-4171-96d2-94f0e9595e39.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-04

Reporting Person: HUTTON RONALD W (Vice President and Treasurer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-04 Restricted Stock Units $0 A 900 Acquired Bio-Rad A Common Stock (900) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 3477.6236 Direct

Footnotes

F1: Includes 7.9680, 6.8111, 7.3343 and 6.3192 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/30/17, 12/29/17, 3/29/18 and 6/29/18, respectively.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.